[Possibilities of using bioparox in the treatment of patients with diseases of the upper airways].
Ovchinnikov
Iu M
IuM
Svishtushkin
V M
VM
Nikiforova
G N
GN
Iarin
Iu M
IuM
Morozova
O A
OA
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000336:Aerosols / Q000627:therapeutic use; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D047630:Depsipeptides; D015521:Ethmoid Sinusitis / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005260:Female; D015522:Frontal Sinusitis / Q000188:drug therapy; D005670:Fusarium; D006801:Humans; D007827:Laryngitis / Q000188:drug therapy / Q000601:surgery; D008297:Male; D015523:Maxillary Sinusitis / Q000188:drug therapy; D008875:Middle Aged; D010612:Pharyngitis / Q000188:drug therapy / Q000601:surgery; D011182:Postoperative Care; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D014068:Tonsillectomy
D000336:Aerosols; D000900:Anti-Bacterial Agents; D047630:Depsipeptides; C014001:fusafungin